Journal article · 2013 · Open access
European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia
Haematologica, 98(12), 1826–1835 · Published 1 December 2013 · DOI 10.3324/haematol.2013.091025
In brief
“European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia” is a 2013 journal article by Diana Averbuch and 12 co-authors, published in Haematologica. OpenAlex counts 689 citations as of 18 November 2026, which puts it in the top 7% of works published in 2013 by citations. It is open access: the full text is free to read at Haematologica.
- Citations
- 689
- Most cited in
- 2023 (78)
- Field-weighted impact
- 13.99
- References
- 91
- Authors
- 13
Abstract
Owing to increasing resistance and the limited arsenal of new antibiotics, especially against Gram-negative pathogens, carefully designed antibiotic regimens are obligatory for febrile neutropenic patients, along with effective infection control. The Expert Group of the 4(th) European Conference on Infections in Leukemia has developed guidelines for initial empirical therapy in febrile neutropenic patients, based on: i) the local resistance epidemiology; and ii) the patient's risk factors for resistant bacteria and for a complicated clinical course. An 'escalation' approach, avoiding empirical carbapenems and combinations, should be employed in patients without particular risk factors. A 'de-escalation' approach, with initial broad-spectrum antibiotics or combinations, should be used only in those patients with: i) known prior colonization or infection with resistant pathogens; or ii) complicated presentation; or iii) in centers where resistant pathogens are prevalent at the onset of febrile neutropenia. In the latter case, infection control and antibiotic stewardship also need urgent review. Modification of the initial regimen at 72-96 h should be based on the patient's clinical course and the microbiological results. Discontinuation of antibiotics after 72 h or later should be considered in neutropenic patients with fever of unknown origin who are hemodynamically stable since presentation and afebrile for at least 48 h, irrespective of neutrophil count and expected duration of neutropenia. This strategy aims to minimize the collateral damage associated with antibiotic overuse, and the further selection of resistance.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Averbuch, D., Orasch, C., Cordonnier, C., Livermore, D. M., Mikulska, M., Viscoli, C., Gyssens, I. C., Kern, W. V., Klyasova, G. A., Marchetti, O., Engelhard, D., Akova, M., & ELN, O. B. O. E. A. J. V. O. E. E. I. E. A. (2013). European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica, 98(12), 1826–1835. https://doi.org/10.3324/haematol.2013.091025
MLA 9
Averbuch, Diana, et al. “European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia.” Haematologica, vol. 98, no. 12, 2013, pp. 1826–1835. https://doi.org/10.3324/haematol.2013.091025.
Chicago
Averbuch, Diana, Christina Orasch, Catherine Cordonnier, David M. Livermore, Małgorzata Mikulska, Claudio Viscoli, Inge C. Gyssens, et al. 2013. “European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia.” Haematologica 98 (12): 1826–1835. https://doi.org/10.3324/haematol.2013.091025.
Harvard
Averbuch, D. et al. (2013) ‘European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia’, Haematologica, 98(12), pp. 1826–1835. doi:10.3324/haematol.2013.091025.
IEEE
D. Averbuch et al., “European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia,” Haematologica, vol. 98, no. 12, pp. 1826–1835, 2013, doi: 10.3324/haematol.2013.091025.
BibTeX
@article{averbuch2013european,
title = {{European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia}},
author = {Averbuch, Diana and Orasch, Christina and Cordonnier, Catherine and Livermore, David M. and Mikulska, Małgorzata and Viscoli, Claudio and Gyssens, Inge C. and Kern, Winfried V. and Klyasova, G. A. and Marchetti, Oscar and Engelhard, Dan and Akova, Murat and ELN, on behalf of ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and},
journal = {Haematologica},
year = {2013},
volume = {98},
number = {12},
pages = {1826--1835},
doi = {10.3324/haematol.2013.091025},
url = {https://doi.org/10.3324/haematol.2013.091025}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 45 | |
| 2018 | 37 | |
| 2019 | 66 | |
| 2020 | 54 | |
| 2021 | 60 | |
| 2022 | 65 | |
| 2023 | 78 | |
| 2024 | 69 | |
| 2025 | 68 | |
| 2026 | 48 |
Its field-weighted citation impact is 13.99: it has been cited 13.99 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- febrile neutropenia
- empirical antibiotic therapy
- antibiotic resistance
- Gram-negative bacteria
- carbapenem resistance
- antibiotic stewardship
- infection control
- epidemiology of resistance
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Averbuch, D., Orasch, C., Cordonnier, C., Livermore, D. M., Mikulska, M., Viscoli, C., Gyssens, I. C., Kern, W. V., Klyasova, G. A., Marchetti, O., Engelhard, D., Akova, M., & ELN, O. B. O. E. A. J. V. O. E. E. I. E. A. (2013). European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica, 98(12), 1826–1835. https://doi.org/10.3324/haematol.2013.091025
How many times has this paper been cited?
689 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Haematologica: sign in and open the PDF from this page.
Who wrote this paper?
Diana Averbuch, Christina Orasch, Catherine Cordonnier, David M. Livermore, Małgorzata Mikulska, Claudio Viscoli, Inge C. Gyssens, Winfried V. Kern, G. A. Klyasova, Oscar Marchetti, Dan Engelhard, Murat Akova and 1 more.
What is the DOI of this paper?
10.3324/haematol.2013.091025, permanently at https://doi.org/10.3324/haematol.2013.091025. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.